Join Growin Stock Community!

Sbc medical group holdings incorporatedSBC.US Overview

US StockIndustrials
(No presentation for SBC)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

SBC AI Insights

SBC Overall Performance

SBC AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

SBC Recent Performance

0.39%

Sbc medical group holdings incorporated

0.28%

Avg of Sector

-0.31%

S&P500

SBC PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

SBC Key Information

SBC Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

SBC Profile

SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally. The company offers advertising and marketing services; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals and facility rentals; construction and design of franchisee clinics; medical equipment; and medical consumables procurement. It provides IT software solutions; breast augmentation, liposuction, and rejuvenation treatments, including treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. The company was founded in 2000 and is headquartered in Irvine, California.

Price of SBC

SBC FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

SBC Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.42
PE Ratio (TTM)
9.19
Forward PE
5.42
PS Ratio (TTM)
2.22
PB Ratio
1.60
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
74.09%
Net Margin
24.28%
Revenue Growth (YoY)
68.06%
Profit Growth (YoY)
59.97%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.42
PE Ratio (TTM)
9.19
Forward PE
5.42
PS Ratio (TTM)
2.22
PB Ratio
1.60
Price-to-FCF
-
Gross Margin
74.09%
Net Margin
24.28%
Revenue Growth (YoY)
68.06%
Profit Growth (YoY)
59.97%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
  • When is SBC's latest earnings report released?

    The most recent financial report for Sbc medical group holdings incorporated (SBC) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating SBC's short-term business performance and financial health. For the latest updates on SBC's earnings releases, visit this page regularly.

  • Where does SBC fall in the P/E River chart?

    According to historical valuation range analysis, Sbc medical group holdings incorporated (SBC)'s current price-to-earnings (P/E) ratio is 7.84, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of SBC?

    According to the latest financial report, Sbc medical group holdings incorporated (SBC) reported an Operating Profit of 15.88M with an Operating Margin of 36.63% this period, representing a growth of 14.79% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is SBC's revenue growth?

    In the latest financial report, Sbc medical group holdings incorporated (SBC) announced revenue of 43.35M, with a Year-Over-Year growth rate of -18.33%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does SBC have?

    As of the end of the reporting period, Sbc medical group holdings incorporated (SBC) had total debt of 28.15M, with a debt ratio of 0.09. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does SBC have?

    At the end of the period, Sbc medical group holdings incorporated (SBC) held Total Cash and Cash Equivalents of 127.43M, accounting for 0.4 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does SBC go with three margins increasing?

    In the latest report, Sbc medical group holdings incorporated (SBC) achieved the “three margins increasing” benchmark, with a gross margin of 70.6%%, operating margin of 36.63%%, and net margin of 29.6%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess SBC's profit trajectory and future growth potential.

  • Is SBC's EPS continuing to grow?

    According to the past four quarterly reports, Sbc medical group holdings incorporated (SBC)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.12. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of SBC?

    Sbc medical group holdings incorporated (SBC)'s Free Cash Flow (FCF) for the period is -20.03M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 632.96% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of SBC?

    The latest valuation data shows Sbc medical group holdings incorporated (SBC) has a Price-To-Earnings (PE) ratio of 7.84 and a Price/Earnings-To-Growth (PEG) ratio of 0.02. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.